CYP3A5 and POR gene polymorphisms as predictors of infection and graft rejection in post-liver transplant patients treated with tacrolimus - a cohort study
Abstract Liver transplantation is the only curative option for patients with advanced stages of liver disease, with tacrolimus used as the immunosuppressive drug of choice. However, due to its narrow therapeutic index and high inter- and intra-individual variability, serum monitoring should be frequ...
Uloženo v:
| Hlavní autoři: | , , , , , , , , , , , |
|---|---|
| Médium: | Pré-impressão |
| Jazyk: | angličtina |
| Vydáno: |
2023
|
| On-line přístup: | https://doi.org/10.21203/rs.3.rs-3399704/v1 https://www.researchsquare.com/article/rs-3399704/latest.pdf |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|